Who is sponsoring NCT04373473?

NCT04373473 is sponsored by The University of Texas Health Science Center, Houston.

What condition does NCT04373473 study?

NCT04373473 studies Adults With Ulcerative Colitis.

What drugs are being tested in NCT04373473?

Interventions: PRIM-DJ2727, Placebos.

What is the status of NCT04373473?

NCT04373473 is currently RECRUITING.

Last reviewed 2026-03-09 · How we verify

Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis

NCT04373473 PHASE2 RECRUITING

The purpose of the study is to evaluate the efficacy and safety of lyophilized PRIM-DJ2727 capsules given orally in subjects with ulcerative colitis at remission stage. This study will also include longitudinal analyses of recipient's gut microbiota taxonomy and metagenomics to determine potential associations with clinical outcomes in context of active FMT or placebo administration.

Details

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	PHASE2
Status	RECRUITING
Enrolment	58
Start date	Mon Sep 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Adults With Ulcerative Colitis

Interventions

PRIM-DJ2727
Placebos

Countries

United States